John Bencich, CFO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 1,380 shares at $0.57 ($787) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market sale of $787 OGXI by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACHV | BUY | 2021-05-27 | $42K | — | Filing → |
| OGXI | SELL | 2016-03-16 | $692 | — | Filing → |
| OGXI | SELL | 2015-08-20 | $4K | — | Filing → |